|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Apoptosis and Cancer
If you have a question about this talk, please contact Lucy Purser.
Meeting website: www.abcam.com/cambridgecancer
A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and inhibitor of apoptosis proteins (IAPs). Discussion sessions will involve members from academia as well as industry.
This talk is part of the Abcam meetings series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsCambridge Carbon Nanotechnology Society British Computer Society SPA Cambridge Education and the State: The State of Education
Other talkstba Evaluating music creativity through an assessment rubric Invariant Measures for a Kinetic Equation Modelling Schooling of Fish TCR requirements for gamma/delta T cell development Hierarchical active matter: from beating bundles to active gels, streaming liquid crystals and motile emulsions Gestational diseases and disorders in pregnancy: prevention, identification, treatment and control